Literature DB >> 18040840

Feline immunodeficiency virus neuropathogenesis: from cats to calcium.

Rick B Meeker1.   

Abstract

Invasion of human immunodeficiency virus (HIV) into the central and peripheral nervous system produces a wide range of neurological symptoms, which continue to persist even with adequate therapeutic suppression of the systemic viremia. The development of therapies designed to prevent the neurological complications of HIV require a detailed understanding of the mechanisms of virus penetration into the nervous system, infection, and subsequent neuropathogenesis. These processes, however, are difficult to study in humans. The identification of animal lentiviruses similar to HIV has provided useful models of HIV infection that have greatly facilitated these efforts. This review summarizes contributions made from in vitro and in vivo studies on the infectious and pathological interactions of feline immunodeficiency virus (FIV) with the nervous system. In vivo studies on FIV have provided insights into the natural progression of CNS disease as well as the contribution of various risk factors. In vitro studies have contributed to our understanding of immune cell trafficking, CNS infection and neuropathogenesis. Together, these studies have made unique contributions to our understanding of (1) lentiviral interactions at the blood-cerebrospinal fluid (CSF) barrier within the choroid plexus, (2) early FIV invasion and pathogenesis in the brain, and (3) lentiviral effects on intracellular calcium deregulation and neuronal dysfunction. The ability to combine in vitro and in vivo studies on FIV offers enormous potential to explore neuropathogenic mechanisms and generate information necessary for the development of effective therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 18040840      PMCID: PMC3166855          DOI: 10.1007/s11481-006-9045-z

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  163 in total

1.  HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy.

Authors:  Jutta K Neuenburg; Hans R Brodt; Brian G Herndier; Markus Bickel; Peter Bacchetti; Richard W Price; Robert M Grant; Wolfgang Schlote
Journal:  J Acquir Immune Defic Syndr       Date:  2002-10-01       Impact factor: 3.731

Review 2.  Cellular mechanisms of feline immunodeficiency virus (FIV)-induced neuropathogenesis.

Authors:  E Zenger; E Tiffany-Castiglioni; E W Collisson
Journal:  Front Biosci       Date:  1997-11-01

3.  Cortical neuronal cytoskeletal changes associated with FIV infection.

Authors:  S Jacobson; S J Henriksen; O Prospero-Garcia; T R Phillips; J H Elder; W G Young; F E Bloom; H S Fox
Journal:  J Neurovirol       Date:  1997-08       Impact factor: 2.643

4.  Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.

Authors:  M C Strain; S Letendre; S K Pillai; T Russell; C C Ignacio; H F Günthard; B Good; D M Smith; S M Wolinsky; M Furtado; J Marquie-Beck; J Durelle; I Grant; D D Richman; T Marcotte; J A McCutchan; R J Ellis; J K Wong
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  The HIV-1 coat protein gp120 and some of its fragments potently activate native cerebral NMDA receptors mediating neuropeptide release.

Authors:  A Gemignani; P Paudice; A Pittaluga; M Raiteri
Journal:  Eur J Neurosci       Date:  2000-08       Impact factor: 3.386

6.  FIV induced encephalopathy: early brain lesions in the absence of viral replication in monocyte/macrophages. A pathogenetic model.

Authors:  L Silvotti; A Corradi; G Brandi; A Cabassi; M Bendinelli; M Magnan; G Piedimonte
Journal:  Vet Immunol Immunopathol       Date:  1997-03       Impact factor: 2.046

Review 7.  The neuropathogenesis of AIDS.

Authors:  Francisco González-Scarano; Julio Martín-García
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

8.  Is AZT/3TC therapy effective against FIV infection or immunopathogenesis?

Authors:  Maki Arai; Donald D Earl; Janet K Yamamoto
Journal:  Vet Immunol Immunopathol       Date:  2002-03       Impact factor: 2.046

9.  Comparisons of HIV-1 viral sequences in brain, choroid plexus and spleen: potential role of choroid plexus in the pathogenesis of HIV encephalitis.

Authors:  H Chen; C Wood; C K Petito
Journal:  J Neurovirol       Date:  2000-12       Impact factor: 2.643

10.  Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus.

Authors:  C D Ackley; J K Yamamoto; N Levy; N C Pedersen; M D Cooper
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

View more
  15 in total

1.  Suppression of immunodeficiency virus-associated neural damage by the p75 neurotrophin receptor ligand, LM11A-31, in an in vitro feline model.

Authors:  Rick B Meeker; Winona Poulton; Wen-hai Feng; Lola Hudson; Frank M Longo
Journal:  J Neuroimmune Pharmacol       Date:  2011-12-10       Impact factor: 4.147

2.  FIV diversity: FIV Ple subtype composition may influence disease outcome in African lions.

Authors:  Jennifer L Troyer; Melody E Roelke; Jillian M Jespersen; Natalie Baggett; Valerie Buckley-Beason; Dan MacNulty; Meggan Craft; Craig Packer; Jill Pecon-Slattery; Stephen J O'Brien
Journal:  Vet Immunol Immunopathol       Date:  2011-06-12       Impact factor: 2.046

3.  Strain-specific viral distribution and neuropathology of feline immunodeficiency virus.

Authors:  Craig Miller; Helle Bielefeldt-Ohmann; Martha MacMillan; Salvador Huitron-Resendiz; Steven Henriksen; John Elder; Susan VandeWoude
Journal:  Vet Immunol Immunopathol       Date:  2011-06-12       Impact factor: 2.046

4.  Interleukin 10 mediated by herpes simplex virus vectors suppresses neuropathic pain induced by human immunodeficiency virus gp120 in rats.

Authors:  Wenwen Zheng; Wan Huang; Shue Liu; Roy C Levitt; Keith A Candiotti; David A Lubarsky; Shuanglin Hao
Journal:  Anesth Analg       Date:  2014-09       Impact factor: 5.108

5.  Early detection of neuropathophysiology using diffusion-weighted magnetic resonance imaging in asymptomatic cats with feline immunodeficiency viral infection.

Authors:  Daniel S Bucy; Mark S Brown; Helle Bielefeldt-Ohmann; Jesse Thompson; Annette M Bachand; Michelle Morges; John H Elder; Sue Vandewoude; Susan L Kraft
Journal:  J Neurovirol       Date:  2011-07-23       Impact factor: 2.643

6.  The use of a T-maze to measure cognitive-motor function in cats (Felis catus).

Authors:  Barbara L Sherman; Margaret E Gruen; Rick B Meeker; Bill Milgram; Christina DiRivera; Andrea Thomson; Gillian Clary; Lola Hudson
Journal:  J Vet Behav       Date:  2013-01       Impact factor: 1.975

Review 7.  The neuropathogenesis of feline immunodeficiency virus infection: barriers to overcome.

Authors:  Nicola F Fletcher; Rick B Meeker; Lola C Hudson; John J Callanan
Journal:  Vet J       Date:  2010-04-24       Impact factor: 2.688

8.  A rat model of human immunodeficiency virus 1 encephalopathy using envelope glycoprotein gp120 expression delivered by SV40 vectors.

Authors:  Jean-Pierre Louboutin; Lokesh Agrawal; Beverly A S Reyes; Elisabeth J Van Bockstaele; David S Strayer
Journal:  J Neuropathol Exp Neurol       Date:  2009-05       Impact factor: 3.685

9.  Glial TNFα in the spinal cord regulates neuropathic pain induced by HIV gp120 application in rats.

Authors:  Wenwen Zheng; Handong Ouyang; Xuexing Zheng; Shue Liu; Marina Mata; David J Fink; Shuanglin Hao
Journal:  Mol Pain       Date:  2011-05-20       Impact factor: 3.395

Review 10.  Blood-brain barrier abnormalities caused by HIV-1 gp120: mechanistic and therapeutic implications.

Authors:  Jean-Pierre Louboutin; David S Strayer
Journal:  ScientificWorldJournal       Date:  2012-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.